THC - Tenet Healthcare Corporation
| Previous close | 27.80 |
| Open | 26.94 |
| Bid | 27.51 x 800 |
| Ask | 27.90 x 1100 |
| Day's range | 26.02 - 27.96 |
| 52-week range | 17.18 - 39.37 |
| Volume | 388,804 |
| Avg. volume | 1,016,378 |
| Market cap | 2.687B |
| Beta (5Y monthly) | 1.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.32 |
| Earnings date | 26 Apr 2020 - 30 Apr 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 12 Mar 2000 |
| 1y target est | 38.71 |
- Business Wire
Tenet to Participate in the Raymond James 41st Annual Institutional Investors Conference
Tenet Healthcare Corporation (NYSE: THC) will participate in the Raymond James 41st Annual Institutional Investors Conference in Orlando, Florida on Monday, March 2. Members of senior management will speak at the conference at approximately 7:30 a.m. Eastern time (6:30 a.m. Central time).
- Simply Wall St.
Tenet Healthcare Corporation Just Released Its Annual Results And Analysts Are Updating Their Estimates
There's been a notable change in appetite for Tenet Healthcare Corporation (NYSE:THC) shares in the week since its...
- Zacks
Tenet Healthcare (THC) Q4 Earnings Miss Estimates, Rise Y/Y
Tenet Healthcare's (THC) fourth-quarter results reflect improved performance of Ambulatory Care and Hospital segments, offset by poor performance of Conifer segment.
- Zacks
Tenet Healthcare (THC) Q4 Earnings Lag Estimates
Tenet (THC) delivered earnings and revenue surprises of -1.98% and 1.10%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2019 and Issues Financial Outlook for 2020
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2019 (4Q19).
- Zacks
What's in Store for Tenet Healthcare's (THC) Q4 Earnings?
Tenet Healthcare's (THC) Q4 results are likely to reflect higher revenues, aided by its Hospital and Other Operations as well as Ambulatory segments, partly offset by lower admissions.
- Zacks
Tenet Healthcare (THC) Earnings Expected to Grow: Should You Buy?
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
5 High Earnings Yield Stocks to Build a Successful Portfolio
While comparing stocks, if other factors are similar, the stock with a higher earnings yield is considered undervalued.
- Zacks
Tenet Healthcare (THC) Gains As Market Dips: What You Should Know
Tenet Healthcare (THC) closed at $33.97 in the latest trading session, marking a +1.62% move from the prior day.
- Zacks
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks
The Zacks Analyst Blog Highlights: Cross Country Healthcare, KB Home, Hilton Grand Vacations, Tenet Healthcare and G-III Apparel
The Zacks Analyst Blog Highlights: Cross Country Healthcare, KB Home, Hilton Grand Vacations, Tenet Healthcare and G-III Apparel
- Zacks
U.S. Labor Market on a Solid Footing: Top 5 Winners
The U.S. economy added 225,000 jobs in January as workers rejoin the labor force and wages rise slightly. Here's a rundown on the strong job growth's big winners --
- Zacks
The Zacks Analyst Blog Highlights: Community Health, Tenet, Rite Aid, Chipotle and Domino's
The Zacks Analyst Blog Highlights: Community Health, Tenet, Rite Aid, Chipotle and Domino's
- Zacks
5 Solid Buys From the U.S. Service Sector Boom
Services side of the economy expanded at the fastest pace in January since last summer. The increase in the new order index and improving measure of business activity pointed to underlying strength.
- Zacks
Solid Start to February as Stocks Stage Partial Rebound
Solid Start to February as Stocks Stage Partial Rebound
- Business Wire
Tenet to Report its Fourth Quarter Results on Feb. 24
Tenet Healthcare Corporation (NYSE: THC) plans to report results for its fourth quarter ended December 31, 2019, after the market closes on Monday, Feb. 24, 2020. The company will host a conference call the following morning, Tuesday, Feb. 25, at 10:00 a.m. Eastern time (9:00 a.m. Central time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors. The audio archive will be available on Tenet’s website for approximately 30 days.
- Zacks
Dose of Bright Near-Term Outlook From Medical-Hospital Industry
Dose of Bright Near-Term Outlook From Medical-Hospital Industry
- Simply Wall St.
Did Tenet Healthcare's (NYSE:THC) Share Price Deserve to Gain 98%?
One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with...
- Zacks
Is Tenet Healthcare (THC) A Suitable Pick for Value Investors?
Is Tenet Healthcare (THC) a great pick from the value investor's perspective right now? Read on to know more.
- Business Wire
Tenet Reports Inducement Awards under NYSE Rule 303A.08
Tenet Healthcare Corporation (NYSE: THC) announced the issuance today of restricted stock unit awards to Joseph F. Eazor, the new President and Chief Executive Officer of Tenet’s Conifer Health Solutions business unit. These awards were issued to induce Mr. Eazor to enter into employment with Conifer and were issued outside of Tenet’s shareholder-approved stock incentive plan, in reliance on the inducement award exception contained in NYSE Listing Rule 303A.08.
- Business Wire
Tenet Names Joe Eazor President and CEO of Conifer
Tenet Healthcare Corporation (NYSE: THC) today announced the appointment of Joseph F. Eazor as President and Chief Executive Officer of its Conifer Health Solutions business. Eazor is a seasoned executive with a distinguished career in technology and business process services. He has held the CEO role and other top leadership positions at public and private companies, with expertise that spans strategy, customer engagement, product development, global sales and marketing, outsourcing, and mergers and acquisitions.
